(Q36823061)

16 August 2017

title

Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain (English)

1 reference

16 August 2017

Zhang SP

1

1 reference

16 August 2017

Zhou LW

2

1 reference

16 August 2017

Morabito M

3

1 reference

16 August 2017

Lin RC

4

1 reference

16 August 2017

Weiss B

5

1 reference

16 August 2017

publication date

1 January 1996

1 reference

Journal of Molecular Neuroscience

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

13-28

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02736845

16 August 2017

exact match

0 references

cites work

Characterization of oligonucleotide transport into living cells

1 reference

12 December 2020

Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity

1 reference

12 December 2020

Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain

1 reference

12 December 2020

Modified oligonucleotides as therapeutic and diagnostic agents

1 reference

12 December 2020

ANTISENSE oligonucleotides: a new tool in neuroscience

1 reference

12 December 2020

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

12 December 2020

Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake

1 reference

12 December 2020

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

12 December 2020

Pharmacokinetics of antisense oligonucleotides

1 reference

12 December 2020

Cellular uptake of phosphorothioate oligodeoxynucleotides is negatively affected by cell density in a transformed rat tracheal epithelial cell line: implication for antisense approaches

1 reference

12 December 2020

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

12 December 2020

In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.

1 reference

12 December 2020

Making sense out of anti-sense: challenges of imaging gene translation with radiolabeled oligonucleotides

1 reference

12 December 2020

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

12 December 2020

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

1 reference

12 December 2020

Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulate reproductive behavior in the female rat.

1 reference

12 December 2020

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate

1 reference

12 December 2020

Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats

1 reference

12 December 2020

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

1 reference

12 December 2020

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1 reference

12 December 2020

Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides

1 reference

12 December 2020

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

12 December 2020

Therapeutic Applications of Oligonucleotides

1 reference

12 December 2020

In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue

1 reference

12 December 2020

The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo

1 reference

12 December 2020

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

12 December 2020

Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?

1 reference

12 December 2020

Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine

1 reference

12 December 2020

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

12 December 2020

Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin

1 reference

12 December 2020

Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

1 reference

12 December 2020

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

12 December 2020

Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine.

1 reference

12 December 2020

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

1 reference

12 December 2020

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1 reference

12 December 2020

Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects

1 reference

12 December 2020

Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02736845

1 reference

release_ygnhsojep5hx5evcsf6ewwdl5a

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ygnhsojep5hx5evcsf6ewwdl5a

24 November 2022

mapped directly with Wikidata item

1 reference